...
首页> 外文期刊>FEMS immunology and medical microbiology >Changes in T-cell subpopulations during four years of suppression of HIV-1 replication in patients with advanced disease.
【24h】

Changes in T-cell subpopulations during four years of suppression of HIV-1 replication in patients with advanced disease.

机译:晚期疾病患者抑制HIV-1复制的四年中T细胞亚群的变化。

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract We compared the number/percentages of naive and memory CD4(+) T-cells, CD38(+)CD8(+) T-cells, and CD28(+)CD4(+) and CD28(+)CD8(+) T-cells in patients with advanced HIV disease (baseline CD4(+) count<100) with those with less advanced (baseline CD4(+) cell count>100) HIV disease during 4 years of suppressive highly active antiretroviral therapy. This prospective, longitudinal study included 30 treatment-naive patients and 32 controls. Advanced HIV-infected patients (n=13) gained more CD4(+) T-cells than less advanced patients (n=11) at 1 month (median: 60 vs. 36muL(-1)), 3 months (86 vs. 14), 6 months (111 vs. 23), 12 months (174 vs. 47), 24 months (162 vs. 72) and 48 months (257 vs. 123) (P=0.15, P<0.001, P=0.026, P=0.021, P=0.1 and P=0.06, respectively). Advanced patients gained more naive CD4(+) T-cells at 48 months compared to less advanced patients (27.3 vs. 11.4%, P=0.05). The relative gain in memory CD4(+) T-cells was greater in advanced vs. less advanced patients at 1 month (median: 6.4vs. 1.4%), 3 months (4.3 vs. 2.0), 6 months (6.7 vs. 1.6), 12 months (6.9 vs. 2.4), 24 months (7.5 vs. 3.1) and 48 months (11.3 vs. 6.8) (P=0.002, P=0.013, P<0.001, P=0.004, P=0.001 and P=0.015, respectively). At 48 months, CD38(+)CD8(+) T-cells and naive CD4(+) T-cells reached normal values (9.2%, P=0.869 vs. controls and 47.5%, P=0.699, respectively) in less advanced patients, as did CD38(+)CD8(+) T-cells in advanced patients (4.7%, P=0.309 vs. controls). The kinetics of naive and memory CD4(+) T-cell reconstitution is different in less advanced compared to advanced HIV patients.
机译:摘要我们比较了幼稚和记忆CD4(+)T细胞,CD38(+)CD8(+)T细胞,CD28(+)CD4(+)和CD28(+)CD8(+)T细胞的数量/百分比在抑制性高活性抗逆转录病毒疗法治疗的4年中,患有晚期HIV疾病(基线CD4(+)计数<100)的HIV-细胞和患有晚期HIV(基线CD4(+)细胞计数> 100)的艾滋病毒的细胞。这项前瞻性,纵向研究包括30例未经治疗的患者和32例对照。在1个月(中位数:60 vs. 36muL(-1)),3个月(86 vs. 16)中,晚期HIV感染患者(n = 13)获得的CD4(+)T细胞比不那么晚期患者(n = 11)更多。 14),6个月(111对23),12个月(174对47),24个月(162对72)和48个月(257对123)(P = 0.15,P <0.001,P = 0.026 ,分别为P = 0.021,P = 0.1和P = 0.06)。晚期患者在48个月时获得的幼稚CD4(+)T细胞更多,而晚期患者则获得了更多的CD4(+)T细胞(27.3比11.4%,P = 0.05)。 1个月(中位数:6.4vs。1.4%),3个月(4.3 vs. 2.0),6个月(6.7 vs. 1.6)的晚期患者较晚期患者记忆CD4(+)T细胞的相对增益更高。 ),12个月(6.9 vs.2.4),24个月(7.5 vs.3.1)和48个月(11.3 vs.6.8)(P = 0.002,P = 0.013,P <0.001,P = 0.004,P = 0.001和P分别为0.015)。在48个月时,进展较轻的CD38(+)CD8(+)T细胞和幼稚CD4(+)T细胞达到正常值(分别为对照组的9.2%,P = 0.869和对照的47.5%,P = 0.699)。患者,晚期患者的CD38(+)CD8(+)T细胞也是如此(4.7%,与对照组相比,P = 0.309)。天真和记忆CD4(+)T细胞重构的动力学与晚期HIV患者相比,在晚期患者中有所不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号